CLINICAL_TRIALS
trial_result
· 2025-12-23
Clinical Trial Update: Ribociclib and Letrozole Treatment in Ovarian Cancer [Phase 2]
Summary
Phase 2 trial results for ribociclib in combination with letrozole in low-grade serous ovarian carcinoma have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynecologic Oncology Group | Conditions: Low Grade Serous Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-12-23